Is Corteva, Inc. overvalued or undervalued?

As of 7 November 2025, Corteva, Inc. has moved from expensive to fair valuation. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 37, a Price to Book Value of 2.01, and an EV to EBITDA of 14.55. In comparison, a peer like Corteva, Inc. shows a higher P/E of 33.44, indicating that while it is perceived as very expensive, it still reflects a competitive landscape in the Chemicals & Petrochemicals industry.
Recent stock performance reveals that Corteva has outperformed the S&P 500 over the past week with a return of 4.41% compared to the S&P 500's -1.63%, although it has lagged behind over longer periods, such as the 3-year and 10-year returns. Overall, the valuation metrics suggest that Corteva is fairly valued relative to its peers and market conditions.